Loading current stock analysis…
Loading current stock analysis…
India
As of 18 Sept 2026, 03:30 pm
For the first quarter of fiscal year 2027 (Q1 FY27), Navin Fluorine International reported consolidated revenue of ₹1,045.1 crore, marking a 44% increase year-over-year and an 11% increase quarter-over-quarter. Profit After Tax (PAT) for the quarter was ₹243.31 crore, an increase of 108% year-over-year. The company also announced capital expenditure plans, including a Phase II cGMP4 expansion of ₹125 crore, expected to be operational by Q4 FY27, and an additional HFC capacity expansion of ₹236.5 crore, targeted for commissioning by Q3 FY27.
As of September 18, 2026, the daily trend for Navin Fluorine International is indicated as bullish, with the closing price at ₹8,590.0. The Super Trend indicator is also bullish at ₹8,156.82. The nearest identified resistance level is ₹8,757.75, which is 1.95% above the current price, and a support level is noted at ₹8,528.33, which is 0.72% below the current price.
Navin Fluorine International officials were scheduled to interact with analysts and investors on September 16 and 17, 2026, via the Jefferies India Forum. Additionally, an in-person analyst meeting was scheduled for September 21, 2026, at 10:00 AM in Mumbai as part of the Anand Rathi G-200 Summit 2026, where the company's outlook was to be discussed.
On September 15, 2026, Navin Fluorine International received a rating of '64.54 Performer' from Niche99 ESG Ratings, based on an independent review of public domain data. The company stated that it did not engage Niche99 for this assessment.
As of 18 Sept 2026, 03:30 pm
Recent drawdown and price variability remain within the producer's contained-risk thresholds.
Primary driver: Price swings are higher than typical
Trading activity was substantially higher than usual and the price closed higher.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
The session traded across a materially wider price range than usual.
Larger price swings can increase short-term uncertainty, especially if they continue.
Trading volume was unusually high, but the closing price did not show a clear directional move.
This indicates increased participation without a clear directional signal.
The session opened materially below the previous close, indicating a sharp repricing at the open.
The price gap may increase short-term downside uncertainty and warrants review of the underlying context.
Latest complete financial results for Q1 FY2027 and comparative quarterly trends.
| Metric | Q1 FY2026-27(Latest) | Q4 FY2025-26 | Q3 FY2025-26 | Q2 FY2025-26 | Q1 FY2025-26 |
|---|---|---|---|---|---|
| Revenue From Operations | PEAK₹1,045.08 crore | ₹937.71 crore | ₹892.37 crore | ₹758.42 crore | ₹725.40 crore |
| Income | PEAK₹1,080.17 crore | ₹955.30 crore | ₹907.95 crore | ₹776.63 crore | ₹739.31 crore |
| Expenses | PEAK₹761.81 crore | ₹686.72 crore | ₹649.22 crore | ₹579.13 crore | ₹584.20 crore |
| Profit Before Exceptional Items And Tax | PEAK₹318.36 crore | ₹268.58 crore | ₹258.73 crore | ₹197.50 crore | ₹155.11 crore |
| Profit Before Tax | PEAK₹318.36 crore | ₹282.30 crore | ₹238.26 crore | ₹197.50 crore | ₹155.11 crore |
| Profit Loss For Period | PEAK₹243.31 crore | ₹212.62 crore | ₹185.40 crore | ₹148.37 crore | ₹117.16 crore |
Navin Fluorine International Ltd. reported its financial results for the first quarter of FY2026-27 (quarter ended June 30, 2026). Revenue from operations grew 44% year-on-year to ₹1,045.08 crore, while net profit more than doubled to ₹243.31 crore. Total expenses rose at a slower pace, expanding margins, and the quarter had no exceptional items.
Revenue from operations reached ₹1,045.08 crore, a 44.07% increase over ₹725.40 crore in Q1 FY26. The company recorded its fifth consecutive quarter of sequential revenue growth, with a quarter-on-quarter rise of 11.45% from ₹937.71 crore in Q4 FY26.
Total expenses were ₹761.81 crore, up 30.4% from ₹584.20 crore a year ago, well below the 44% revenue increase. Other expenses rose 13.77% year-on-year (2.85% sequentially) to ₹151.69 crore. Finance costs increased 5.83% year-on-year to ₹32.12 crore. Because expenses grew more slowly than revenue, profit before exceptional items and tax jumped 105.25% to ₹318.36 crore.
Navin Fluorine’s first quarter delivered sharp year‑on‑year revenue and profit growth. Expenses expanded at a slower rate than revenue, helping net profit more than double. Both revenue and net profit have increased sequentially for five straight quarters. The absence of exceptional items makes the underlying profit comparison straightforward.
Exchange disclosures and regulatory announcements for Navin Fluorine International.
On September 15, 2026, Navin Fluorine International Limited received an email from Niche99 ESG Ratings assigning the company a rating of '64.54 Performer' based on an independent review of public domain data. The company clarified that it did not engage Niche99 for this assessment and noted that the report is available at www.niche99.com. This intimation was filed with the National Stock Exchange and BSE on September 16, 2026, by President Legal and Company Secretary Niraj B. Mankad.
Newspaper advertisement regarding opening of the Special Window for transfer and dematerialisation (demat) of physical shares |SUBJECT: Copy of Newspaper Publication
Navin Fluorine International Limited reported Q1 FY27 consolidated revenue of Rs. 1,045.1 crore, up 44% YoY and 11% QoQ, with a PAT of Rs. 243.31 crore, up 108% YoY. The company announced a Phase II cGMP4 capex of Rs. 125 crore, expected to be operational by Q4 FY27, and an additional HFC capacity capex of Rs. 236.5 crore for commissioning by Q3 FY27. Officials will interact with analysts and investors on September 21, 2026, at the Anand Rathi G-200 Summit.
Navin Fluorine International Limited announced on September 7, 2026, that its officials will interact with analysts and investors via the Jefferies India Forum on September 16 and 17, 2026. The company disclosed Q1 FY27 consolidated net revenue of Rs. 1,045.1 Crs, representing a 44% year-over-year increase, alongside a Profit After Tax of Rs. 243.31 Crs. Additionally, the filing detailed ongoing capital expenditure programs, including a Rs. 125 Cr Phase II cGMP4 expansion expected to operationalize by Q4 FY27 and a Rs. 236.5 Cr HFC capacity addition targeted for commissioning in Q3 FY27.
Navin Fluorine International Limited announced an in-person analyst meeting scheduled for September 21, 2026, at 10:00 AM in Mumbai as part of the Anand Rathi G-200 Summit 2026. The company's Managing Director and Chief Financial Officer will meet with representatives from MUFG Intime India Private Limited, specifically Mr. Nitin Kulkarni and Mr. Anish Ganatra. The event includes a presentation and is intended to discuss the firm's outlook under the theme 'Bharat - The Next Engine of Global Growth'.
Navin Fluorine International Limited will participate in the 2026 Jefferies India Forum in Mumbai, with in-person group meetings on September 16 and 17, 2026. Managing Director Mr. Nitin Kulkarni and CFO Mr. Anish Ganatra will meet with MUFG Intime India Private Limited. A presentation will accompany the meetings.
On August 26, 2026, Navin Fluorine International Limited allotted equity shares under its ESOP/ESPS scheme following a board meeting approval on the same date. The allotment increased the paid-up share capital from INR 102,591,978 to INR 102,608,168 and raised the total number of shares outstanding from 51,300,019 to 51,308,114.
On August 26, 2026, Navin Fluorine International Limited's Nomination and Remuneration Committee allotted 8,095 equity shares to eligible employees under the Employees' Stock Option Scheme 2017 upon exercise of stock options. Following this allotment, the company's paid-up share capital increased to ₹10,26,08,168, comprising 5,13,00,054 fully paid equity shares and 8,060 partly paid equity shares. The newly issued shares rank pari-passu with existing equity shares.
Recent market and company developments associated with Navin Fluorine International.
In its note, Mahesh Nandurkar of Jefferies wrote about the recent surge in gold prices in the global markets, highlighting that Indians hold gold worth nearly $4 trillion, nearly 4x the money they hold in stocks.
Kotak Securities highlighted the potential implications of a larger-scale expansion by Chemours. If Chemours proceeds with such an expansion, Navin Fluorine could face substantial associated capital expenditure, after which management would need to evaluate the optimal financing structure.
BSE shares, BSE stock, L&T shares, Larsen & Toubro shares, Bharat Forge shares, Navin Fluorine shares, Sundram Fasteners shares, Avinash Gorakshkar, NSE IPO, F&O segment, auto ancillary stocks, chemical stocks, stock market, Indian stock market, Business Today
Navin Fluorine's shares jumped 14% to ₹8.647, following strong quarterly results. Brokerages raised target prices, with Axis Securities lifting it to ₹8,600, while JM Financial also raised its target price on the stock to ₹9,000 from ₹8,200
Sensex Today | Stock Market LIVE Updates: The markets are once again moving on a cautious note, with the Nifty trading flat around the 24,600 mark. The Nifty Bank is also in the same state, trying to scale the 58,000 mark. Titan, Reliance and Eternal are the top gainers.
Navin Fluorine, Navin Fluorine share, Navin Fluorine share price, Navin Fluorine target prices 2026, Navin Fluorine news, NFIL, NFIL share price, NFIL share, NFIL share price today
Q1 Results Today, 06th August 2026 Live Updates: Follow Q1FY27 live updates frmo businessline
Q1 Results LIVE Updates; Trent, Britannia, Lupin, Samvardhana Motherson, Apollo Tyres, Blue Star, Premier Energies, HCC, NCC, PG Electroplast, Emcure Pharma, Firstsource Solutions are some of the many companies that will be reporting their results during the course of Thursday's trading session on Dalal Street. Result reactions today come from PB Fintech, Aurobindo Pharma, Cummins India, GE Vernova T&D, ION Exchange and many others. Watch this space for all the LIVE Q1 result updates, management and brokerage commentary along with stock moves.
Comprehensive Section Breakdown for Navin Fluorine International
Strategic Vision: Indian manufacturer of specialty fluorochemicals for diverse industries.
• Deep fluorochemical expertise
• Backward-integrated manufacturing for key brands
• Commitment to quality, safety, and sustainability certifications
Net profit from continuing operations was ₹243.31 crore, up 107.66% year-on-year from ₹117.17 crore and 14.43% higher than the previous quarter’s ₹212.62 crore. Basic earnings per share rose 100.8% to ₹47.45 (Q1 FY26: ₹23.63). The effective tax rate was 23.6%, slightly lower than 24.5% in the same quarter last year. Profit before tax and profit before exceptional items were identical at ₹318.36 crore, meaning no exceptional items affected the quarter—unlike the two preceding quarters, where the figures differed.
Navin Fluorine delivered a strong Q1 FY27 with consolidated revenue of ₹1,045.1 Cr (+44% YoY) and operating EBITDA margin expanding 566 bps YoY to 34.2%. All three business verticals posted robust growth: HPP (+33% YoY) benefited from constructive pricing and volume, Specialty (+48% YoY) was underpinned by strong order visibility, and CDMO (+82% YoY) reflected deeper engagement with a European CDMO major. Management highlighted that the AHF facility commenced operations in Q4 FY26 and is being ramped up, while the Chemours project is targeted for completion by end of Q2 FY27.
Looking ahead, the Board approved a ₹90 Cr capex for Advanced Materials adoption capacities at Surat (completion Q2 FY28) to incubate a new high-growth vertical focused on Data Centers, Electronics, Defence & Semiconductors. Other ongoing capex includes additional HFC capacity of 15,000 MTPA (₹236.5 Cr, Q3 FY27), MPP debottlenecking at Dahej (₹75 Cr, Q3 FY27), and Phase II of cGMP4 (₹125 Cr, Q4 FY27). Management expects peak revenue potential of ~₹600-825 Cr p.a. from the HFC capex and ~₹140-160 Cr p.a. from the MPP expansion, reinforcing its strategy of building scalable platforms and nurturing long-term partnerships.
Category: Manufacturing
This division focuses on manufacturing refrigerants and fluorochemicals, emphasizing safety, consistency, and long-term performance.
Category: Manufacturing
This segment provides fluorinated intermediates that support complex synthesis routes for pharmaceuticals, agrochemicals, and other specialty applications.
Category: B2B Services
Through Navin Molecular, the company offers custom research and manufacturing services, assisting global innovators from early development stages through to commercial supply.
Category: Manufacturing
This division is dedicated to developing emerging fluorine-based materials for high-performance and next-generation applications.
Core Thesis: The company leverages its innovation and deep fluorochemical expertise across its divisions to serve diverse industries.
• Fluorochemical Expertise: The company's deep expertise in fluorochemicals is a foundational element across its business divisions. • Innovation and Development: Focus on developing new solutions and materials for various industries, including emerging technologies. • Custom Manufacturing Services: Offering custom research and manufacturing services to global innovators from development to commercial supply.